Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results
Year: 2009
Type: book-chapter
Parent work: Lipid A in Cancer Therapy
Author: Christopher W. Cluff
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: monophosphoryl lipid A, MPL, cancer vaccines, vaccine adjuvants, tumor-associated antigens, TLR4, lipopolysaccharide, dendritic cells, macrophages, antitumor immunity, clinical trials, melanoma, breast cancer, prostate cancer, ovarian cancer, glioma, hepatocellular carcinoma, renal cell carcinoma
Open Access status: closed
OpenAlex ID: W1576543020
